Corxel to Go Public Through Amanat Acquisition With $300 Million Investment
Corxel Pharmaceuticals plans to merge with blank-check company Amanat Acquisition to go public. The combination is backed by an oversubscribed $300 million private investment from healthcare funds.
By Adriano MarcheseObesity drugmaker Corxel Pharmaceuticals plans to go public by merging with blank-check company Amanat Acquisition as it advances its experimental oral obesity pill.The combination is bolstered by an oversubscribed $300 million private investment from healthcare funds, with parti…